Paul Goepfert

机构：University of Alabama at Birmingham · ORCID：0000-0001-8441-5737

发表论文 344 篇 · 总被引 17402 次 · h-index 64

代表论文

• 2024 Update of the RECOVER-Adult Long COVID Research Index (2024 · JAMA · 被引 79)
• Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort (2024 · Annals of Internal Medicine · 被引 50)
• Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial (2025 · Science Translational Medicine · 被引 44)
• Identification of soluble biomarkers that associate with distinct manifestations of long COVID (2025 · Nature Immunology · 被引 35)
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial (2024 · Nature Communications · 被引 21)
• Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort (2025 · Nature Communications · 被引 20)